|
|
|
|
||
Re: ASCOThe demand for Yescarta far outstrips the supply. Most patients don't survive 6 months without the one time infusion. With the infusion they are living 2 years and longer. The longer Yescarta CR, the bigger the usage. A chance at life, or no chance at all! |
return to message board, top of board |